ASCO 2024 Recap

Ainhoa Madariaga on Frailty Assessments in Ovarian Cancer | ASCO 2024Подробнее

A. Edward Yen - Prostate Cancer Highlights from GU ASCO and ASCO 2024Подробнее

Topline Bio x Uromigos: 2024 Year in Review - ASCO GUПодробнее

ASCO 2024: How to Best Use New Breast Cancer DataПодробнее

Highlights in lung cancer from ASCO 2024Подробнее

Key melanoma highlights from ASCO 2024, including RELATIVITY-048 and NADINA trialsПодробнее

Highlights from ASCO 2024Подробнее

Topline Bio x Uromigos: 2024 Year in Review - ASCOПодробнее

ASCO Michigan 2024 | Highlights from ASCO in Non-Small Cell Lung CancerПодробнее

SFA Education Session: ASCO Review 2024Подробнее

Multiple Myeloma: Key Take-home Messages from EHA and ASCO 2024Подробнее

Prostate Cancer Research Updates: ASCO 2024 | ZERO Prostate CancerПодробнее

Best of ASCO UAE 2024 | HighlightsПодробнее

ASCO 2024 HighlightsПодробнее

ASCO 2024 annual conference highlightsПодробнее

ASCO 2024 Top 3 Practice Changing Head & Neck Cancer StudiesПодробнее

What’s New In Diffuse Large B-Cell LymphomaUpdates from ASCO 2024 & the EHA Hybrid CongressПодробнее

2024 ASCO Kidney Cancer HighlightsПодробнее

2024 ASCO Prostate Cancer HighlightsПодробнее